Noncoding RNA-mediated Macrophage and Cancer Cell Crosstalk in Hepatocellular Carcinoma
Overview
Authors
Affiliations
The tumor microenvironment (TME) is a well-recognized system that plays an essential role in tumor initiation, development, and progression. Intense intercellular communication between tumor cells and other cells (especially macrophages) occurs in the TME and is mediated by cell-to-cell contact and/or soluble messengers. Emerging evidence indicates that noncoding RNAs (ncRNAs) are critical regulators of the relationship between cells within the TME. In this review, we provide an update on the regulation of ncRNAs (primarily micro RNAs [miRNAs], long ncRNAs [lncRNAs], and circular RNAs [circRNAs]) in the crosstalk between macrophages and tumor cells in hepatocellular carcinoma (HCC). These ncRNAs are derived from macrophages or tumor cells and act as oncogenes or tumor suppressors, contributing to tumor progression not only by regulating the physiological and pathological processes of tumor cells but also by controlling macrophage infiltration, activation, polarization, and function. Herein, we also explore the options available for clinical therapeutic strategies targeting crosstalk-related ncRNAs to treat HCC. A better understanding of the relationship between macrophages and tumor cells mediated by ncRNAs will uncover new diagnostic biomarkers and pharmacological targets in cancer.
Complicated crosstalk between HMGA and non-coding RNAs modulates hallmarks of cancer.
Zhang L, Zhao X, Gao X, Qin H, Chen F, Lin Z Cancer Cell Int. 2025; 25(1):80.
PMID: 40055693 PMC: 11887209. DOI: 10.1186/s12935-025-03713-1.
Comparison and benchmark of deep learning methods for non-coding RNA classification.
Creux C, Zehraoui F, Radvanyi F, Tahi F PLoS Comput Biol. 2024; 20(9):e1012446.
PMID: 39264986 PMC: 11421803. DOI: 10.1371/journal.pcbi.1012446.
Li D, Zhang T, Guo Y, Bi C, Liu M, Wang G Cell Death Dis. 2024; 15(7):498.
PMID: 38997297 PMC: 11245522. DOI: 10.1038/s41419-024-06888-z.
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.
Zhao L, Wang G, Qi H, Yu L, Yin H, Sun R Cell Mol Biol Lett. 2024; 29(1):77.
PMID: 38769475 PMC: 11103861. DOI: 10.1186/s11658-024-00592-8.
Huang S, Wu Z, Zhou Y Eur J Med Res. 2024; 29(1):159.
PMID: 38475969 PMC: 10929223. DOI: 10.1186/s40001-024-01753-3.